Implementing and personalizing best-in-class opioid-sparing pain management for major inpatient surgeries in children

Active Cooperative Agreement Awarded Last action

Award ID
U01HD116257
Recipient
Awarding agency
Obligated
$13,418,622

Award facts

Assistance listing
93.279 Drug Use and Addiction Research Programs
Completion date 43% complete
Funding agency
National Institute of Neurological Disorders and Stroke National Institutes of Health, Department of Health and Human Services
Place of performance
Pittsburgh, PA 15222, USA

Award details come from USAspending.gov.

Description

Abstract
The multicenter precise analgesia (prospective randomized evaluation of analgesia for cardiac and idiopathic scoliosis spine fusion elective surgery in children) trials will a) implement and in- vestigate the efficacy and safety of multidose methadone-based standardized enhanced recovery after surgery (eras) protocol, and b) develop personalized eras protocols including precision methadone and oxycodone dosing and personalized analgesia for the safe and effective opioid-sparing management of surgical pain after posterior spine fusion (PSF) and cardiac surgery (CS) in children. PSF and CS are both extremely painful SUR- geries in children requiring long hospital stays and high opioid use associated with adverse effects (AES), high incidence of opioid dependence (OD), and chronic post-surgical pain (cpsp). Post-discharge prescribed oxyco- done is used for >1-2 weeks, and opioid dependence occurs within 5 days in children. 20-50% of children develop cpsp, largely due to severe uncontrolled acute surgical pain, contributing to life-long risks for opioid use/misuse and the ongoing opioid epidemic. There is an urgent need for safe, effective opioid-sparing analgesia as well as proactive risk predictions and personalized analgesia to provide best-in-class immediate surgical pain relief while minimizing the risk of opioid-induced respiratory depression (RD), sedation, postoperative nausea and vomiting (ponv), cpsp and persistent opioid use/misuse. Recently, we showed that a methadone- based standardized eras protocol shortened hospital stays (2-4 days), reduced prescribed opioid use (5-7 VS. 7-18 days), and the risks of cpsp. Despite this improvement, with standardized methadone eras, 30-40% of children still experi- enced uncontrolled severe pain, ponv, and sedation from methadone and oxycodone. Our preliminary data show that CYP2B6 and ORM1 genotypes and alpha acid glycoprotein (AAG) contribute to the variation in phar- macokinetics (PK), analgesia, and adverse outcomes. Our preliminary data in children undergoing CS with car- DIO-pulmonary bypass (CPB) reveal opioid-sparing and safe postoperative analgesia with methadone. We will now study the effect of CPB on intraoperative methadone dosing with robust PK modeling to enable precision methadone dosing for the first time in children. Our expert multidisciplinary team will enroll a total of 1000 children to conduct two parallel randomized clinical trials for PSF (500 children 12-

Transactions

Action Obligated Date
Amendment $3,293,523
Amendment $3,315,439
Amendment $0
Amendment $3,404,830
Original award $3,404,830

Subawards

Subrecipient Amount Awarded
The Regents Of The University Of California. San Francisco Implementing and Personalizing Best-In-Class Opioid-sparing Pain Management for Major Inpatient Surgeries in Children $0
Childrens Hospital Medical Center $174,022
The Regents Of The University Of California. San Francisco $69,463
Childrens Hospital Medical Center $60,000
Baylor College Of Medicine $135,000
Baylor College Of Medicine $82,654
The Regents Of The University Of California. San Francisco $69,451
Indiana University (1673) $77,711
Childrens Hospital Medical Center Cincinnati Children's Hospital Medical Center 3333 Burnet Avenue ML 7030 Cincinnati, Ohio 45229-3039 $174,022

Quick answers

Who received award U01HD116257?

U01HD116257 was awarded to University Of Pittsburgh - Of The Commonwealth System Of Higher Education by National Institute of Child Health and Human Development (National Institutes of Health) on September 5, 2024.

How much is award U01HD116257 worth?

$13,418,622 has been obligated on U01HD116257.

Which agency awarded U01HD116257?

National Institute of Child Health and Human Development (National Institutes of Health) awarded U01HD116257, with funding from National Institute of Neurological Disorders and Stroke (National Institutes of Health).

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award